Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

CUSIP: 29970R204

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
Shares outstanding
315,652,014
Total 13F shares
806,483
Share change
-284,270
Total reported value
$681,502
Price per share
$0.85
Number of holders
9
Value change
-$277,604
Number of buys
3
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 29970R204?
CUSIP 29970R204 identifies EVAX - Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) as of Q4 2024

As of 31 Dec 2024, Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 806,483 shares. The largest 9 holders included Merck & Co., Inc., ARMISTICE CAPITAL, LLC, Invst, LLC, Catalina Capital Group, LLC, MILLENNIUM MANAGEMENT LLC, Beacon Capital Management, LLC, JPMORGAN CHASE & CO, RHUMBLINE ADVISERS, and SouthState Corp. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.